Original Literature | Model OverView |
---|---|
Publication
Title
Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4.
Affiliation
Molecular Immunology & Inflammation Branch, NIAMS, National Institutes ofHealth, Bethesda, MD 20892-1820, USA.
Abstract
Produced in response to a variety of pathogenic organisms, interleukin (IL)-12and IL-23 are key immunoregulatory cytokines that coordinate innate and adaptiveimmune responses. These dimeric cytokines share a subunit, designated p40, andbind to a common receptor chain, IL-12R beta 1. The receptor for IL-12 iscomposed of IL-12R beta 1 and IL-12R beta 2, whereas IL-23 binds to a receptorcomposed of IL-12R beta 1 and IL-23R. Both cytokines activate the Janus kinasesTyk2 and Jak2, the transcription factor signal transducer and activator oftranscription 4 (STAT4), as well as other STATs. A major action of IL-12 is topromote the differentiation of naive CD4+ T cells into T-helper (Th) 1 cells,which produce interferon (IFN)-gamma, and deficiency of IL-12, IL-12R subunitsor STAT4 is similar in many respects. In contrast, IL-23 promotes end-stageinflammation. Targeting IL-12, IL-23, and their downstream signaling elementswould therefore be logical strategies for the treatment of immune-mediateddiseases.
PMID
15546391
|
Entity
p38
--
MO000000022
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m66
10
infinite
0
TRANSPATH | MO000000022 |
--
PI3K{active}
--
MO000000030
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m73
10
infinite
0
TRANSPATH | MO000000030 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m19
10
infinite
0
TRANSPATH | MO000000058 |
--
Jak2
--
MO000000146
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m130
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000146 |
--
STAT1{active}
--
MO000013119
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1357
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013119 |
--
STAT3
--
MO000013122
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1360
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000013122 |
--
STAT4
--
MO000017181
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2053
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000017181 |
--
STAT3{p}
--
MO000021607
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m5950
10
infinite
0
TRANSPATH | MO000021607 |
--
STAT4{pY}
--
MO000033720
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m12383
10
infinite
0
TRANSPATH | MO000033720 |
--
IL-12Rbeta1
--
MO000034025
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m12587
10
infinite
0
InterPro | IPR003961 |
TRANSPATH | MO000034025 |
--
IL-12Rbeta2
--
MO000034026
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m12588
10
infinite
0
InterPro | IPR003961 |
TRANSPATH | MO000034026 |
--
sphingosine
--
MO000034420
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m356991
10
infinite
0
TRANSPATH | MO000034420 |
--
Lck{p}
--
MO000038421
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16631
10
infinite
0
TRANSPATH | MO000038421 |
--
T-bet
--
MO000090987
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m64461
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000090987 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
MCP1:MCP1 receptor
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m11
0
infinite
0
--
prostaglandin E2:prostaglandin E2 receptor
--
e12
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m12
0
infinite
0
--
histamine:histamine receptor
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
FcR crosslinking
--
e14
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m14
0
infinite
0
--
CCR5 receptor: CCR5 ligand
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
cholera toxin
--
e16
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
IL12-p40
--
e17
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m17
0
infinite
0
--
IL12-p40:transcription factors
--
e18
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m18
0
infinite
0
--
ICSBP
--
e19
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
csml-variable:Double
m21
0
infinite
0
--
IL-12Rbeta1:TYK2:IL-12A
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
IL-12Rbeta2:JAk2{p}:IL-12B
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
IFN-gamma
--
e23
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
TBX21
--
e24
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m25
0
infinite
0
--
IL12Rbeta2
--
e25
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m26
0
infinite
0
--
IL-23R
--
e26
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m27
0
infinite
0
--
IL-23
--
e27
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m28
0
infinite
0
--
IL-23:IL-12betaR1:TYK2:IL-23R:Jak2
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
IL-12Rbeta1:TYK2
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IL-12Rbeta2:JAk2
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
IL-23R:Jak2
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
IL-12Rbeta2:JAk2:IL-12B
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
IL-12Rbeta2{p}:JAk2{p}:IL-12B
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
IL-12Rbeta2{p}:JAk2{p}:IL-12B:stat4
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
IL-12Rbeta2{p}:JAk2{p}:IL-12B:stat4{p}
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
(Stat4{p})2
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
(Stat4{p})2
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
IFN-gamma
--
e38
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m39
0
infinite
0
--
IFN-gamma:(Stat4{p})2
--
e39
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IFN-gamma
--
e40
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
IL-23:IL-12betaR1:TYK2:IL-23R:Jak2{p}
--
e41
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
IL-23:IL-12betaR1:TYK2:IL-23R{p}:Jak2{p}
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
IL-23:IL-12betaR1:TYK2:IL-23R{p}:Jak2{p}:stat3
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
IL-23:IL-12betaR1:TYK2:IL-23R{p}:Jak2{p}:stat3{p}
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
(stat3{p})2
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
(stat3{p})2
--
e46
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
IFN-gamma:(stat3{p})2
--
e47
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m48
0
infinite
0
--
IL-17
--
e48
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m49
0
infinite
0
--
IL-17:(stat3{p})2
--
e49
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m63
0
infinite
0
--
Il-12
--
e5
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
type I interferon
--
e6
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
IL-17
--
e63
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m64
0
infinite
0
--
MKK3{p}
--
e64
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
p38{p}
--
e65
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m67
0
infinite
0
--
csml-variable:Double
m68
0
infinite
0
--
SB203850
--
e67
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
SPHk2
--
e68
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
sphingosine 1-phosphate
--
e69
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
IL12Rbeta1:SPHK2
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m72
0
infinite
0
--
PIASx
--
e75
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m79
0
infinite
0
--
STAT4:PIASx
--
e76
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m80
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
STAT5{active}
--
e80
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m84
10
infinite
0
TRANSPATH | MO000016876 |
--
STAT4{active}
--
e81
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m85
10
infinite
0
InterPro | IPR008967 |
TRANSPATH | MO000017181 |
--
TCR:TCR ligand
--
e82
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m86
0
infinite
0
--
Stat4
--
e83
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m87
0
infinite
0
--
IL-18R
--
e84
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m88
0
infinite
0
--
type I IFNs
--
e85
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m89
0
infinite
0
--
type I IFNs
--
e86
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m90
0
infinite
0
--
IL-2R:(stat4{p})2:CBP:c-jun
--
e87
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m91
0
infinite
0
--
csml-variable:Double
m92
0
infinite
0
--
IL-2R
--
e89
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m93
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
csml-variable:Double
m95
0
infinite
0
--
csml-variable:Double
m96
0
infinite
0
--
p1
p1
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c3 : 1
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
stoichiometry:c10 : 1
stoichiometry:c14 : 1
stoichiometry:c2 : 1
m5*0.1
nodelay
--
0
PMID: 15546391, 7836910, 9000540, 10993913, 9548515, 11859138, 8760828, 8557999, 11207258 IL-12 production is inhibited by other cytokines including IL-10, IL-11, IL-13 and type I interferons (IFNs) PMID: 15546391, 12009566 G-protein-coupled receptors (GPCRs), including the receptors for monocyte chemoattractant protein 1 (MCP-1), prostaglandin E2, histamine, and FcR cross-linking, also inhibit IL-12 production, although some GPCRs like CCR5 positively regulate production PMID: 15546391, 11169439, 9294136 Cholera toxin and measles virus also downregulate IL-12 production
p10
p10
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m12587*m132*0.1
nodelay
--
0
PMID: 15546391, 12023369, 7528775, 9038232 IL-12Rb1 binds the Janus kinase (Jak) family member Tyk2, whereas IL-12Rb2 and IL-23R associate with Jak2.
p11
p11
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m130*m12588*0.1
nodelay
--
0
PMID: 15546391, 12023369, 7528775, 9038232 IL-12Rb1 binds the Janus kinase (Jak) family member Tyk2, whereas IL-12Rb2 and IL-23R associate with Jak2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m27*m130*0.1
nodelay
--
0
PMID: 15546391, 12023369, 7528775, 9038232 IL-12Rb1 binds the Janus kinase (Jak) family member Tyk2, whereas IL-12Rb2 and IL-23R associate with Jak2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m33*0.1
nodelay
--
0
PMID: 15546391 Ligand binding brings the receptor chains and associated Jaks (Jak2 and Tyk2) in close proximity, resulting in Jak transphosphorylation and subsequent phosphorylation of the receptor chains by activated Jaks.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
m23*0.1
nodelay
--
0
PMID: 15546391 Ligand binding brings the receptor chains and associated Jaks (Jak2 and Tyk2) in close proximity, resulting in Jak transphosphorylation and subsequent phosphorylation of the receptor chains by activated Jaks.
p15
p15
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c147 : 1
stoichiometry:c55 : 1
m34*m2053*0.1
nodelay
--
0
PMID: 15546391 IL-12Rb2 is phosphorylated and serves as a docking site for STAT4. STAT4 binds to the receptor chain and is itself phosphorylated. PMID: 15546391, 14559241 SOCS-3 has been reported to be a negative regulator of IL-12 signaling by preventing STAT4 binding to the IL-12Rb2 subunit
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m35*0.1
nodelay
--
0
PMID: 15546391 IL-12Rb2 is phosphorylated and serves as a docking site for STAT4. STAT4 binds to the receptor chain and is itself phosphorylated.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m36*0.1
nodelay
--
0
PMID: 15546391 From figure 1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m12383*0.1
nodelay
--
0
PMID: 15546391 From figure 1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m37*0.1
nodelay
--
0
PMID: 15546391 STAT4 homodimers shuttle into the nucleus where they bind to STATbinding sites in the interferon IFN-gamma promoter and, through mechanisms that are not entirely clear, induce transcription of the IFN-g gene
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c13 : 1
stoichiometry:c12 : 1
m5*m15*0.1
nodelay
--
0
PMID: 15546391, 12009566 G-protein-coupled receptors (GPCRs), including the receptors for monocyte chemoattractant protein 1 (MCP-1), prostaglandin E2, histamine, and FcR cross-linking, also inhibit IL-12 production, although some GPCRs like CCR5 positively regulate production.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m38*m39*0.1
nodelay
--
0
PMID: 15546391 STAT4 homodimers shuttle into the nucleus where they bind to STATbinding sites in the interferon IFN-gamma promoter and, through mechanisms that are not entirely clear, induce transcription of the IFN-g gene. PMID: 15546391 Using chromatin immunoprecipitation assay, the binding of STAT4 to the IFNG gene has now been documented. PMID: 15546391, 12242445, 9558063, 15280353 In both mouse (90) and human (193, 264), STAT4 has been shown to interact with the IFNG gene in the promoter/introns.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m40*0.1
nodelay
--
0
PMID: 15546391 STAT4 homodimers shuttle into the nucleus where they bind to STATbinding sites in the interferon IFN-gamma promoter and, through mechanisms that are not entirely clear, induce transcription of the IFN-g gene
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m29*0.1
nodelay
--
0
PMID: 15546391 IL-23 stimulation also activates the Jaks and STATs, but STAT3, and not STAT4, appears to be the predominant STAT activated.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
m42*0.1
nodelay
--
0
PMID: 15546391 IL-23 stimulation also activates the Jaks and STATs, but STAT3, and not STAT4, appears to be the predominant STAT activated.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m43*m1360*0.1
nodelay
--
0
PMID: 15546391 IL-23 stimulation also activates the Jaks and STATs, but STAT3, and not STAT4, appears to be the predominant STAT activated.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m44*0.1
nodelay
--
0
PMID: 15546391 IL-23 stimulation also activates the Jaks and STATs, but STAT3, and not STAT4, appears to be the predominant STAT activated.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m45*0.1
nodelay
--
0
PMID: 15546391 IL-23 stimulation also activates the Jaks and STATs, but STAT3, and not STAT4, appears to be the predominant STAT activated.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m5950*0.1
nodelay
--
0
PMID: 15546391 IL-23 stimulation also activates the Jaks and STATs, but STAT3, and not STAT4, appears to be the predominant STAT activated.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m46*0.1
nodelay
--
0
PMID: 15546391 IL-23 stimulation also activates the Jaks and STATs, but STAT3, and not STAT4, appears to be the predominant STAT activated.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m47*m39*0.1
nodelay
--
0
PMID: 15546391 IL-23 induces IFN-g production as well as the production of the proinflammatory cytokine IL-17.
p3
p3
cso30:i:ME_DNABinding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
stoichiometry:c16 : 1
m17*m970*m19*m165*m20*m21*0.1
nodelay
--
0
PMID: 15546391, 8551218, 7565674, 9099678, 9234715, 10861061, 11058167, 9497375, 12876285 Several transcription factors have been shown to bind to the mouse and human p40 promoters including nuclear factor (NF)-kB, IFN-regulatory factor (IRF)-1, c-Rel, IFN consensus binding protein (ICSBP, also called IRF-8), and Ets family members
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m48*0.1
nodelay
--
0
PMID: 15546391 IL-23 induces IFN-g production as well as the production of the proinflammatory cytokine IL-17.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c91 : 1
m63*0.1
nodelay
--
0
PMID: 15546391 IL-23 induces IFN-g production as well as the production of the proinflammatory cytokine IL-17.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m47*m64*0.1
nodelay
--
0
PMID: 15546391 IL-23 induces IFN-g production as well as the production of the proinflammatory cytokine IL-17.
p33
p33
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c98 : 1
stoichiometry:c97 : 1
m123*m34*0.1
nodelay
--
0
PMID: 15546391, 7553885 In NK cells, the Src family protein tyrosine kinase Lck is tyrosine phosphorylated in response to IL-12 signaling in both resting and activated cells, and IL-12 stimulation also increased in vitro Lck autophosphorylation
p34
p34
cso30:i:ME_Autophosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c101 : 1
stoichiometry:c100 : 1
m123*m34*0.1
nodelay
--
0
PMID: 15546391, 7553885 In NK cells, the Src family protein tyrosine kinase Lck is tyrosine phosphorylated in response to IL-12 signaling in both resting and activated cells, and IL-12 stimulation also increased in vitro Lck autophosphorylation
p35
p35
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c104 : 1
stoichiometry:c103 : 1
m1875*m34*0.1
nodelay
--
0
PMID: 15546391, 10961885, 10201984, 10903740 IL-12 evidently does not activate p42/44 ERK or JNK; however, both p38 MAPK and its upstream activator MKK3/6 are activated in response to IL-12 signaling
p36
p36
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c107 : 1
stoichiometry:c106 : 1
m3613*m34*0.1
nodelay
--
0
PMID: 15546391, 10961885, 10201984, 10903740 IL-12 evidently does not activate p42/44 ERK or JNK; however, both p38 MAPK and its upstream activator MKK3/6 are activated in response to IL-12 signaling
p37
p37
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c113 : 1
stoichiometry:c109 : 1
m66*m16567*0.1
nodelay
--
0
PMID: 15546391, 10961885, 10201984, 10903740 IL-12 evidently does not activate p42/44 ERK or JNK; however, both p38 MAPK and its upstream activator MKK3/6 are activated in response to IL-12 signaling
p38
p38
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c112 : 1
stoichiometry:c111 : 1
m66*m65*0.1
nodelay
--
0
PMID: 15546391, 10961885, 10201984, 10903740 IL-12 evidently does not activate p42/44 ERK or JNK; however, both p38 MAPK and its upstream activator MKK3/6 are activated in response to IL-12 signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c120 : 1
stoichiometry:c115 : 1
m67*0.1
nodelay
--
0
PMID: 15546391, 10903740 Moreover, activation of p38 MAPK is required for IFN-g production in response to IL-12 stimulation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c22 : 1
stoichiometry:c24 : 1
m21349*m30*0.1
nodelay
--
0
PMID: 15546391 IL-12p40 interacts predominantly with the beta1 subunit, whereas p35 interacts largely with the beta2 subunit.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c117 : 1
m41*m67*0.1
nodelay
--
0
PMID: 15546391, 10903740 Moreover, activation of p38 MAPK is required for IFN-g production in response to IL-12 stimulation. PMID: 15546391, 9582275 The IFN-g production is blocked by the p38 MAPK inhibitor SB203850 or expression of a dominant negative p38 transgene
p41
p41
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c123 : 1
stoichiometry:c122 : 1
m2053*m67*0.1
nodelay
--
0
PMID: 15546391, 10903740, 10961885 p38 MAPK mediates STAT4 serine phosphorylation in response to IL-12 stimulation
p42
p42
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c126 : 1
stoichiometry:c125 : 1
m356991*m70*0.1
nodelay
--
0
PMID: 15546391, 12011102 Sphingosine kinase 2 (SPHK2) catalyzes the phosphorylation of sphingosine to sphingosine 1-phosphate (S1P), and the latter has been suggested to be an important intracellular messenger that promotes cell proliferation and survival
PMID: 15546391, 12011102 Sphingosine kinase 2 (SPHK2) catalyzes the phosphorylation of sphingosine to sphingosine 1-phosphate (S1P), and the latter has been suggested to be an important intracellular messenger that promotes cell proliferation and survival
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m70*m12587*0.1
nodelay
--
0
PMID: 15546391, 12874225 Using yeast two-hybrid studies, it was reported that SPHK2 associates with IL-12Rb1, and expression of SPHK2 in a T-cell clone augmented IL-12- induced STAT4 transcriptional activation and IFN-g production,while having no effect on proliferation
p45
p45
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c133 : 1
stoichiometry:c132 : 1
m66*m71*0.1
nodelay
--
0
PMID: 15546391, 11415936 S1P has been reported to activate p38 MAPK in endothelial cells
p46
p46
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c139 : 1
stoichiometry:c135 : 1
m74*m1954*0.1
nodelay
--
0
PMID: 15546391, 9390691 The phosphatidylinositol 3-kinase (PI3K)/Akt-signaling pathway is activated by numerous cytokines, including IL-2, contributing to cell proliferation and antagonizing apoptosis
p47
p47
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c136 : 1
stoichiometry:c138 : 1
stoichiometry:c137 : 1
m75*m73*0.1
nodelay
--
0
PMID: 15546391, 9390691 The phosphatidylinositol 3-kinase (PI3K)/Akt-signaling pathway is activated by numerous cytokines, including IL-2, contributing to cell proliferation and antagonizing apoptosis
PMID: 15546391, 9390691 The phosphatidylinositol 3-kinase (PI3K)/Akt-signaling pathway is activated by numerous cytokines, including IL-2, contributing to cell proliferation and antagonizing apoptosis
p49
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c143 : 1
stoichiometry:c142 : 1
m172*m34*0.1
nodelay
--
0
PMID: 15546391, 9768751 In DCs, IL-12 activates p50 and RelB NF-kB transcription factors
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c25 : 1
stoichiometry:c27 : 1
m21351*m31*0.1
nodelay
--
0
PMID: 15546391 IL-12p40 interacts predominantly with the beta1 subunit, whereas p35 interacts largely with the beta2 subunit.
p50
p50
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c146 : 1
stoichiometry:c145 : 1
m167*m34*0.1
nodelay
--
0
PMID: 15546391, 9768751 In DCs, IL-12 activates p50 and RelB NF-kB transcription factors
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c148 : 1
stoichiometry:c149 : 1
stoichiometry:c150 : 1
m2053*m79*0.1
nodelay
--
0
PMID: 15546391, 12716907 PIASx was shown to inhibit IL-12 signaling by binding to STAT4 and preventing STAT4-dependent gene transcription.
p52
p52
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c151 : 1
stoichiometry:c153 : 1
stoichiometry:c152 : 1
m1360*m34*0.1
nodelay
--
0
PMID: 15546391, 7722452, 8683106, 10201984, 9531298 They include STAT1 (81, 82), STAT3 (12), STAT5 (82), and under certain conditions, STAT6 (83).
p53
p53
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c156 : 1
stoichiometry:c155 : 1
m82*m34*0.1
nodelay
--
0
PMID: 15546391, 7722452, 8683106, 10201984, 9531298 They include STAT1 (81, 82), STAT3 (12), STAT5 (82), and under certain conditions, STAT6 (83).
p54
p54
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c157 : 1
stoichiometry:c159 : 1
stoichiometry:c158 : 1
m1368*m34*0.1
nodelay
--
0
PMID: 15546391, 7722452, 8683106, 10201984, 9531298 They include STAT1 (81, 82), STAT3 (12), STAT5 (82), and under certain conditions, STAT6 (83).
p55
p55
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c162 : 1
stoichiometry:c161 : 1
m1798*m34*0.1
nodelay
--
0
PMID: 15546391, 7722452, 8683106, 10201984, 9531298 They include STAT1 (81, 82), STAT3 (12), STAT5 (82), and under certain conditions, STAT6 (83).
p56
p56
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c165 : 1
stoichiometry:c164 : 1
m82*m43*0.1
nodelay
--
0
PMID: 15546391 IL-23 stimulation results in the activation of STAT1, STAT3, STAT4, and STAT5.
p57
p57
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c168 : 1
stoichiometry:c167 : 1
m1798*m43*0.1
nodelay
--
0
PMID: 15546391 IL-23 stimulation results in the activation of STAT1, STAT3, STAT4, and STAT5.
p58
p58
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c169 : 1
stoichiometry:c171 : 1
stoichiometry:c170 : 1
m2053*m43*0.1
nodelay
--
0
PMID: 15546391 IL-23 stimulation results in the activation of STAT1, STAT3, STAT4, and STAT5.
p59
p59
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c172 : 1
stoichiometry:c174 : 1
stoichiometry:c173 : 1
m2053*m1954*0.1
nodelay
--
0
PMID: 15546391, 9886399, 12759422 Moreover, IL-2, IL-15, and IL-21 have all been reported to activate STAT4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c32 : 1
stoichiometry:c29 : 1
m25*m24*0.1
nodelay
--
0
--
p60
p60
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c175 : 1
stoichiometry:c177 : 1
stoichiometry:c176 : 1
m2053*m1956*0.1
nodelay
--
0
PMID: 15546391, 9886399, 12759422 Moreover, IL-2, IL-15, and IL-21 have all been reported to activate STAT4
p61
p61
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c179 : 1
stoichiometry:c180 : 1
stoichiometry:c178 : 1
m4065*m2053*0.1
nodelay
--
0
PMID: 15546391, 9886399, 12759422 Moreover, IL-2, IL-15, and IL-21 have all been reported to activate STAT4
p62
p62
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c182 : 1
stoichiometry:c183 : 1
stoichiometry:c181 : 1
m2053*m68*0.1
nodelay
--
0
PMID: 15546391, 14657353 The dimeric cytokine IL-27 also triggers STAT4 activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c185 : 1
stoichiometry:c184 : 1
m86*0.1
nodelay
--
0
PMID: 15546391, 7638186 While STAT4 expression is very low in resting T cells, it is upregulated by T-cell receptor (TCR) stimulation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c186 : 1
m34*0.1
nodelay
--
0
PMID: 15546391, 11120802 IL-12 also enhances the expression of the IL-18 receptor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c188 : 1
stoichiometry:c189 : 1
m155666*0.1
nodelay
--
0
PMID: 15546391, 11896392 The authors attribute this to the fact that LPS induces type I IFNs that activate STAT4 and induce IFN-g
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c192 : 1
stoichiometry:c191 : 1
m89*m155666*0.1
nodelay
--
0
PMID: 15546391, 11896392 The authors attribute this to the fact that LPS induces type I IFNs that activate STAT4 and induce IFN-g
p67
p67
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c193 : 1
stoichiometry:c195 : 1
stoichiometry:c194 : 1
m2053*m90*0.1
nodelay
--
0
PMID: 15546391, 11896392 The authors attribute this to the fact that LPS induces type I IFNs that activate STAT4 and induce IFN-g
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c196 : 1
stoichiometry:c198 : 1
stoichiometry:c197 : 1
m41*m85*0.1
nodelay
--
0
PMID: 15546391, 11896392 The authors attribute this to the fact that LPS induces type I IFNs that activate STAT4 and induce IFN-g
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c212 : 1
stoichiometry:c213 : 1
m39*m84*0.1
nodelay
--
0
PMID: 15546391 We have identified an STAT5-binding element 3.6 Kb upstream that seems to be required for IL-2-enhancement of IFN-g expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c30 : 1
m24*0.1
nodelay
--
0
PMID: 15546391, 11752460, 12006974 In Th1 cells, IFN-g stimulation upregulates the transcription factor T-bet, which in turn promotes IL-12Rb2 chain expression
p70
p70
cso30:i:ME_DNABinding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c201 : 1
stoichiometry:c203 : 1
stoichiometry:c204 : 1
stoichiometry:c207 : 1
stoichiometry:c202 : 1
m92*m38*m2282*m94*0.1
nodelay
--
0
PMID: 15546391 In addition, it was demonstrated that IL-12 induces binding of STAT4 to the IL-2R promoter followed by recruitment of CREB-binding protein, associated with increased histone acetylation and decreased methylation of the CD25 promoter. PMID: 15546391 STAT4 also enhances the binding of cJun to the locus.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c205 : 1
stoichiometry:c206 : 1
m91*0.1
nodelay
--
0
PMID: 15546391 IL-12 has been shown to induce IL-2R expression in a STAT4-dependent manner.
p72
p72
cso30:i:ME_DNABinding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c199 : 1
stoichiometry:c208 : 1
stoichiometry:c209 : 1
m64461*m39*0.1
nodelay
--
0
PMID: 15546391, 14607827 Indeed, a T-bet-binding element has been identified recently that is upstream of the IFN-G gene, but the function of element has yet to be determined. PMID: 15546391, 10761931, 11397944 T-bet is another transcription factor that has been implicated as a critical regulator of Th1 differentiation and IFN-g expression. PMID: 15546391, 14607827 A distal, upstream T-bet-binding site has been defined near the same region.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c211 : 1
m95*0.1
nodelay
--
0
PMID: 15546391, 14607827 Indeed, a T-bet-binding element has been identified recently that is upstream of the IFN-G gene, but the function of element has yet to be determined. PMID: 15546391, 10761931, 11397944 T-bet is another transcription factor that has been implicated as a critical regulator of Th1 differentiation and IFN-g expression
p8
p8
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c33 : 1
m64461*0.1
nodelay
--
0
PMID: 15546391, 11752460, 12006974 In Th1 cells, IFN-g stimulation upregulates the transcription factor T-bet, which in turn promotes IL-12Rb2 chain expression PMID: 15546391, 9120387, 9120388, 10566142 In contrast, IL-4 inhibits IL-12Rb2 expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m28*m30*m32*0.1
nodelay
--
0
PMID: 15546391 IL-23 binds a receptor composed of IL-12Rb1 and a second subunit designated IL-23R
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--